Astra Zeneca is a leading global biopharmaceutical company. We believe the best way we can help patients is to focus on breakthrough science to uncover disease mechanisms and develop novel, targeted therapies that interact with them. This is at the heart of our purpose as a company: to push the boundaries of science to deliver life-changing medicines
Astra Zeneca is accelerating the expansion of our geographical footprint in rare diseases following the acquisition of Alexion in 2021. Rare diseases is a high-growth therapy area with rapid innovation and si...